CN104905406A - Preparation method and application of tobacco tip bar containing flavonoids compound essence - Google Patents
Preparation method and application of tobacco tip bar containing flavonoids compound essence Download PDFInfo
- Publication number
- CN104905406A CN104905406A CN201510337665.6A CN201510337665A CN104905406A CN 104905406 A CN104905406 A CN 104905406A CN 201510337665 A CN201510337665 A CN 201510337665A CN 104905406 A CN104905406 A CN 104905406A
- Authority
- CN
- China
- Prior art keywords
- compound essence
- cigarette
- flavone compound
- preparation
- tip bar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 flavonoids compound Chemical class 0.000 title claims abstract description 40
- 241000208125 Nicotiana Species 0.000 title claims abstract description 15
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229930003935 flavonoid Natural products 0.000 title abstract description 8
- 235000017173 flavonoids Nutrition 0.000 title abstract description 8
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 53
- 238000000605 extraction Methods 0.000 claims abstract description 22
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 16
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims abstract description 16
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 8
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 8
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 235000005875 quercetin Nutrition 0.000 claims abstract description 8
- 229960001285 quercetin Drugs 0.000 claims abstract description 8
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 8
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract description 8
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000005493 rutin Nutrition 0.000 claims abstract description 8
- 229960004555 rutoside Drugs 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 239000002904 solvent Substances 0.000 claims abstract description 3
- 229930003944 flavone Natural products 0.000 claims description 42
- 235000011949 flavones Nutrition 0.000 claims description 42
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 36
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000284 extract Substances 0.000 claims description 16
- 238000010992 reflux Methods 0.000 claims description 12
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 claims description 7
- 210000000214 mouth Anatomy 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 14
- 239000000126 substance Substances 0.000 abstract description 9
- 239000000779 smoke Substances 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 abstract 1
- 229960003321 baicalin Drugs 0.000 abstract 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000002485 combustion reaction Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000000197 pyrolysis Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 239000003546 flue gas Substances 0.000 description 12
- 230000000391 smoking effect Effects 0.000 description 12
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- 210000002345 respiratory system Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 7
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 150000002213 flavones Chemical class 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 102000009816 urokinase plasminogen activator receptor activity proteins Human genes 0.000 description 3
- 108040001269 urokinase plasminogen activator receptor activity proteins Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 description 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 210000001552 airway epithelial cell Anatomy 0.000 description 2
- 210000002821 alveolar epithelial cell Anatomy 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 description 1
- 108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000012887 cigarette smoke extract Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/02—Manufacture of tobacco smoke filters
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a preparation method and application of a tobacco tip bar containing flavonoids compound essence. The method includes the steps of firstly, weighing, by weight, 20% to 60% of baicalin, 10% to 40% of rutin, 10% to 40% of catechol and 10% to 40% of quercetin, conducting mixing, conducting backflow extraction with an ethanol solution as extraction solvent, and obtaining an exacting solution through filtering; secondly, evenly spraying the extracting solution into tows; thirdly, drying the tows in the second step; fourthly, sequentially wrapping forming paper and tip bar receiving and arranging paper on the dried tows, and obtaining the tobacco tip bar containing the flavonoids compound essence. The tobacco tip bar containing the flavonoids compound essence does not participate in cigarette combustion, and therefore no new bad substance generated due to pyrolysis can be generated; active ingredient of the tobacco tip bar enters an oral cavity of a human body together with smoke in cigarettes and can directly act on throats, and a good effect of improving the comfort of the throats is achieved.
Description
Technical field
The invention belongs to technical field of cigarettes, be specifically related to a kind of cigarette mouth containing flavone compound essence rod preparation method and application.
Background technology
Natural plants is widely used in tobacco aromatics, is much wherein containing Flavonoid substances.According to the molecular characterization of Flavonoid substances and the power of interelectric active force, Primary Study finds that such material can produce furans and derivative thereof after burning cracking, these materials are the main aroma components in flue gas, camerlsed, fragrant and sweet, roasting perfume can be brought to flue gas, increase perfume quantity and aroma quality.Therefore, in the allotment of essence spice for cigarette, the use of a lot of flavonoids perfume material is had.
Much research also shows, flavone compound has multiple biologically active, except utilizing that it is antibacterial, anti-inflammatory, anti-sudden change, step-down, except the effect such as clearing heat and detoxicating, calm, diuresis, in anti-oxidant, anticancer, anti-cancer, suppresses also have remarkable result in lipase etc.It is the scavenger of most of oxygen radical, thus can the vigor of increased SOD (superoxide dismutase), reduces the generation of MDA (malondialdehyde) and OX-LDL (OxLDL ELISA).It can increase coronary flow, has antagonism to Myocardial Infarction; Protective effect is had to acute myocardial ischemia; Remarkable result is had to treatment coronary heart diseases and angina pectoris, hypertension etc.; To reduction diastolic pressure, prevent and treat arrhythmia cordis, cardiovascular disease and promoting blood circulation and removing blood stasisly also to play an important role.
A large amount of scientific researches is the important risk factor that the various diseases such as chronic respiratory disease, coronary heart disease occurs from the smog that different angles demonstrates tobacco.Long-term smoker generally has that cough, phlegm are many, the symptom of throat itch, has a strong impact on the quality of life of health and the mankind.In addition, the health of passive smoking to women also works the mischief.In order to alleviate in tobacco smog to the harm of human body, in positive publicity, Smoking is harmful to your health and while advice smoking cessation, also should have the harm reduction cigarette of the effects such as easypro larynx by active development.
Throat is the important component part of respiratory tract, is positioned at the confluce of tracheae and esophagus, is also the vitals of human body pronunciation.When smoker is in smoking, what be vulnerable to harmful substances from flue gases impact most is exactly throat.In flue gas, tar is easily trapped in the body of smoking people, is condensed into a kind of emplastic in lung, is attached to trachea-bronchial epithelial cell and the alveolar surface of smoker, produces physics, chemical stimulation, affects the breathing of human body; Long-time smoking can reduce the defense function of bottleneck throat mucous membrane, there will be the sensation such as dry cough, throat's shouting pain, or causes irascibility to cross prosperous because smoking and bring sense of discomfort to throat; So smoke for human respiratory tract, particularly the harm of throat is comparatively large, with the passing of time may cause laryngeal pathological process.
A large amount of correlative study finds the organ that respiratory tract stimulates as direct body contact's ambient atmos, is the main recipient of tobacco infringement.And airway epithelial cell resists the first line of defence of environmental stimuli as respiratory tract, suffered harm is particularly serious.Previously the stimulation of research display cigarette can regulate alveolar epithelium and bronchiolar epithelium plasma urokinase-type plasminogen activator (Urokinase type plasminogen activator, uPA), uPAR Research (urokinase type plasminogen activator receptor, uPAR) system expression change, alveolar epithelial cells uPA and uPAR level raise more remarkable, present uPA advantage state, be beneficial to proteolysis.Bronchial epithelial cell then presents plasma urokinase-type plasminogen activator inhibitor-1 (plasminogen activator inhibitor-1, PAI-1) advantage state, is conducive to fibrillatable and is formed.Two kinds of cells to uPA system expression state is different may the reason of partial interpretation COPD patient pulmonary emphysema and these the two kinds of different pathological changes of small airway fibrillatable.The section of bibliographical information lung tissue of rats is separately had jointly to hatch with cigarette smoke extract, lung tissue of rats lactic dehydrogenase (lactatec dehydrogenate can be increased, LDH) spill and discharge with nitrite NO2-, stimulate nitric oxide synthase type (induced nitric oxide synthase, iNOS) active increase, causes injury of lungs.As can be seen here, long-term fume exposure can cause airway epithelial cell form and function damage, thus the normal physiological function of the upper lower respiratory tract of impact, make smoker produce uncomfortable sensation, even have a strong impact on life quality (quality of life, QOF) and life security.From safeguarding consumer's interests, walking the road of reducing tar and reducing harm, is the developing direction of Chinese-style cigarette.Under the prerequisite meeting consumer's physiology, psychological needs, reduce the adverse effect that it brings consumer throat, promoting throat's comfortableness, is tobacco business scientific research personnel problem demanding prompt solution.
Throat's comfortableness well refers to that the level and smooth exquisiteness of flue gas that consumer experiences when smoking cigarette, oral cavity noresidue, nose larynx are non-stimulated, aftertaste has the impressions such as sweet sense.Laryngeal response mainly concentrates on the impression at oral cavity and respiratory system position in cigarette smoking process, be embodied in fall thorn, reduce phlegm, the improvement of the aspect such as to promote the production of body fluid, suction comfortableness can be realized preferably.
Thorn falls: excitant refers to the impact of flue gas to sense organ.Impression is divided into the stimulation of oral stimulation, nasal cavity and throat stimulate three kinds.Excitant is large, seemingly has " peppery " taste in oral cavity, to draw tears from sb or shed tears sense at nasal cavity, throat can be made to tighten cause cough in throat.
The excitant of flue gas is mainly by acid excessive and alkalescence is excessive and produce, simultaneously also relevant with the moisture, tightness etc. of cigarette in cigarette.Peppery thorn is because alkaline matter is on the high side; Thorn of choking is because Small molecular shot-like particle is on the high side; Spine (burr) is because acidic materials are on the high side.
Flavone compound has the effect of diastole bronchial smooth muscle, is added in cigarette, can weaken the draw effect of flue gas, alleviates the discomfort that smoke-shock causes throat.
Reduce phlegm: the people of long-term smoker generally has pharyngitis to a certain degree, its performance is that phlegm is many and frequently.Harmful substance in flue gas is frequently gathered in respiratory tract, caused by the wriggling accelerating villus fiber.
Flavone compound can reduce the raw phlegm material of flue gas, certainly will can reduce the accumulation of this constituents at respiratory system.In addition, flavone compound can be wriggled by speed line villus fiber, makes harmful substance get rid of external with juice fast, this effect of reducing phlegm just served to a certain extent.
Promote the production of body fluid: Tianjin is saliva, promoting the production of body fluid is exactly make to secrete saliva in oral cavity.Modern medicine is also thought, containing multiple helpful body composition in saliva, promoting the production of body fluid in mouth, it is easypro suitable to quench one's thirst.
Multiple flavone compound has nourishing Yin and promoting production of body fluid, effect that moistening lung is relieved inflammation or internal heat, interior heat is quenched one's thirst.Be added in cigarette, can stimulate oral cavity taste bud and have effect of promoting the production of body fluid, flue gas is more mellow and fuller, with returning sweet sense, reduces withered sense.
A lot of containing Flavonoid substances in tobacco aromatics, but for special for improving throat's comfortableness, there is cough-relieving, reduce phlegm, the composition of effect of relievining asthma have not been reported, and needs for further study.
Summary of the invention
For the deficiencies in the prior art, the invention provides a kind of there is cough-relieving, reduce phlegm, the rod preparation method of the cigarette mouth containing flavone compound essence of effect of relievining asthma and application, flavone compound essence is added in the tow of mouth rod, in cigarette smoking process, play the anti-inflammatory of its excellence, sharp larynx effect, thus improve throat's comfortableness of cigarette smoking, improve cigarette smoking quality.
The present invention solves the problems of the technologies described above adopted technical scheme: provide a kind of cigarette mouth containing flavone compound essence rod preparation method, described preparation method comprises the steps:
1) take by weight percentage the scutelloside of 20% ~ 60%, 10% ~ 40% rutin, the catechol of 10% ~ 40%, the Quercetin of 10% ~ 40%, mixing after ethanolic solution as Extraction solvent refluxing extraction, filter obtain extract;
2) extract is evenly sprayed in tow;
3) then by step 2) in tow dry;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Further, the mass percentage concentration of described ethanolic solution is 70% ~ 90%.
Further, described step 1) in refluxing extraction 2 ~ 4 times, each refluxing extraction 2 ~ 4 hours.
Further, described step 3) in baking temperature be 25 DEG C ~ 40 DEG C.
A kind of cigarette, comprises cigarette mouth rod and pipe tobacco, the rod of the cigarette mouth containing flavone compound essence that described cigarette mouth rod is prepared for method described above.
The present invention has the following advantages:
1, the present invention does not participate in cigarette burning containing the cigarette mouth rod of flavone compound essence, thus can not produce new undesirable substance because of cracking, meets consumer to requirement that is healthy, low evil;
2, the present invention has excellent natural breath containing the cigarette mouth rod of flavone compound essence, can bring uniqueness, strong additional fragrance to cigarette;
3, the present invention enters human oral cavity with flue gas containing the active component of the cigarette mouth rod of flavone compound essence in cigarette, can directly act on throat, play the effect of good raising throat comfortableness;
4, the present invention is containing flavone compound flavor of raw material wide material sources, with low cost, easy to utilize.
Detailed description of the invention
In order to make object of the present invention, technical scheme and advantage clearly understand, below in conjunction with embodiment, the present invention is further elaborated.Specific embodiment described herein only in order to explain the present invention, is not intended to limit the present invention.
Embodiment 1
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 70%, refluxing extraction 2 times, and each extraction 3 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 25 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 1
| Flavones kind | Scutelloside | Rutin | Catechol | Quercetin |
| Percentage by weight | 20％ | 10％ | 30％ | 40％ |
Embodiment 2
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 70%, refluxing extraction 2 times, and each extraction 4 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 35 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 2
| Flavones kind | Scutelloside | Rutin | Catechol | Quercetin |
| Percentage by weight | 30％ | 20％ | 20％ | 30％ |
Embodiment 3
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 80%, refluxing extraction 4 times, and each extraction 2 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 35 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 3
| Flavones kind | Scutelloside | Rutin | Catechol | Quercetin |
| Percentage by weight | 40％ | 30％ | 10％ | 20％ |
Embodiment 4
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 80%, refluxing extraction 2 times, and each extraction 4 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 35 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 4
| Flavones kind | Scutelloside | Rutin | Catechol | Quercetin |
| Percentage by weight | 50％ | 30％ | 10％ | 10％ |
Embodiment 5
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 90%, refluxing extraction 2 times, and each extraction 2 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 40 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 5
| Flavones kind | Scutelloside | Rutin | Catechol | Quercetin |
| Percentage by weight | 60％ | 10％ | 20％ | 10％ |
Embodiment 6
1) mixed according to ratio in table 1 by flavone compound essence, being dissolved in mass percentage concentration is in the ethanolic solution of 90%, refluxing extraction 4 times, and each extraction 2 hours, filters, is mixed to get extract;
2) by step 1) in extract be evenly sprayed in tow;
3) then by step 2) in tow dry at 40 DEG C;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
Table 6
| Flavones kind | Glycyrrhizin | Eugenol | Cyanidenon | Aurantiin |
| Percentage by weight | 25％ | 25％ | 40％ | 10％ |
For caused by smoking " cough, phlegm is many, pant " three large symptoms; with reference to classical respiratory tract antibechic, eliminate the phlegm, on the basis of pharmacodynamic evaluation method of relievining asthma; from multiple different living model, the method being applicable to natural plant extracts respiratory tract protected effect and evaluating is set up in screening, utilizes ammonia induced cough in mice evaluation antitussive effect, the phenol red excretion method of mouse evaluates phlegm-dispelling functions, Guinea pig isolated trachea spiral strip method evaluates antiasthmatic effect.
The rod of the cigarette mouth containing flavone compound essence prepared in above 6 embodiments is engaged with pipe tobacco and makes cigarette, detection of exhaust gas compositions is carried out to cigarette, and carry out phenol reduced rate and compare, specifically see the following form 7
Table 7
* P<0.05, * * P<0.01 compares with the blank cigarette group of equal number
To engage with pipe tobacco the rod of the cigarette mouth containing flavone compound essence prepared in embodiment in above 6 embodiments and make cigarette, carry out sensory evaluation to cigarette, result is as table 8
Table 8
The above; be only the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, anyly belongs to those skilled in the art in the technical scope that the present invention discloses; the change that can expect easily or replacement, all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain of claim.
Claims (5)
1., containing a cigarette mouth rod preparation method for flavone compound essence, it is characterized in that: described preparation method comprises the steps:
1) take by weight percentage the scutelloside of 20% ~ 60%, 10% ~ 40% rutin, the catechol of 10% ~ 40%, the Quercetin of 10% ~ 40%, mixing after ethanolic solution as Extraction solvent refluxing extraction, filter obtain extract;
2) extract is evenly sprayed in tow;
3) then by step 2) in tow dry;
4) dried tow is wrapped up with forming paper and mouth rod tipping paper successively, the obtained cigarette mouth rod containing flavone compound essence.
2. the rod of the cigarette mouth containing flavone compound essence preparation method according to claim 1, is characterized in that: the mass percentage concentration of described ethanolic solution is 70% ~ 90%.
3. the cigarette mouth rod preparation method containing flavone compound essence according to claim 1 and 2, is characterized in that: described step 1) in refluxing extraction 2 ~ 4 times, each refluxing extraction 2 ~ 4 hours.
4. the cigarette mouth rod preparation method containing flavone compound essence according to claim 1 and 2, is characterized in that: described step 3) in baking temperature be 25 DEG C ~ 40 DEG C.
5. a cigarette, comprises cigarette mouth rod and pipe tobacco, it is characterized in that: described cigarette mouth rod is the rod of the cigarette mouth containing flavone compound essence prepared by the arbitrary described method of Claims 1 to 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510337665.6A CN104905406B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing flavone compound mouth stick preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510337665.6A CN104905406B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing flavone compound mouth stick preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104905406A true CN104905406A (en) | 2015-09-16 |
| CN104905406B CN104905406B (en) | 2018-11-13 |
Family
ID=54075187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510337665.6A Active CN104905406B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing flavone compound mouth stick preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104905406B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107400107A (en) * | 2017-07-26 | 2017-11-28 | 云南中烟工业有限责任公司 | A kind of flavone compound in rose waste residue and preparation method and application |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0568526A (en) * | 1991-09-12 | 1993-03-23 | T Hasegawa Co Ltd | Preparation of extract for tobacco flavoring |
| US5435325A (en) * | 1988-04-21 | 1995-07-25 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts using a solvent in a supercritical state |
| CN1280463A (en) * | 1997-09-19 | 2001-01-17 | 提翁国际股份有限公司 | Smoking products containing antioxidants |
| CN1781388A (en) * | 2004-12-03 | 2006-06-07 | 李忠 | Wild chrysanthemam flower low harm cigarette capable of reducing cigarette harm |
| CN102994231A (en) * | 2012-10-25 | 2013-03-27 | 罗瑞雪 | Preparation method of flavor for baicalin tobaccos |
| WO2013192413A1 (en) * | 2012-06-20 | 2013-12-27 | Mishra Munmaya K | Smokeless tobacco comprising lipid granules |
| CN104068467A (en) * | 2014-07-01 | 2014-10-01 | 安徽中烟工业有限责任公司 | Electronic cigarette liquid rich in plant flavone |
-
2015
- 2015-06-17 CN CN201510337665.6A patent/CN104905406B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5435325A (en) * | 1988-04-21 | 1995-07-25 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts using a solvent in a supercritical state |
| JPH0568526A (en) * | 1991-09-12 | 1993-03-23 | T Hasegawa Co Ltd | Preparation of extract for tobacco flavoring |
| CN1280463A (en) * | 1997-09-19 | 2001-01-17 | 提翁国际股份有限公司 | Smoking products containing antioxidants |
| CN1781388A (en) * | 2004-12-03 | 2006-06-07 | 李忠 | Wild chrysanthemam flower low harm cigarette capable of reducing cigarette harm |
| WO2013192413A1 (en) * | 2012-06-20 | 2013-12-27 | Mishra Munmaya K | Smokeless tobacco comprising lipid granules |
| CN102994231A (en) * | 2012-10-25 | 2013-03-27 | 罗瑞雪 | Preparation method of flavor for baicalin tobaccos |
| CN104068467A (en) * | 2014-07-01 | 2014-10-01 | 安徽中烟工业有限责任公司 | Electronic cigarette liquid rich in plant flavone |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107400107A (en) * | 2017-07-26 | 2017-11-28 | 云南中烟工业有限责任公司 | A kind of flavone compound in rose waste residue and preparation method and application |
| CN107400107B (en) * | 2017-07-26 | 2020-06-16 | 云南中烟工业有限责任公司 | Flavonoid compound in rose waste residue and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104905406B (en) | 2018-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104905405B (en) | The cigarette of the essence containing plant flavone mouth stick preparation method and application | |
| JP5002178B2 (en) | Antitussive composition containing a plant extract | |
| CN101666062A (en) | Tipping paper added with Chinese herbal medicinal additive and preparation method thereof | |
| CN105154227B (en) | Cigarette plant flavone essence cigarette pearl, preparation method and application | |
| CN105029689B (en) | Cigarette flavone compound essence cigarette pearl, preparation method and application | |
| CN100574633C (en) | Health-care granada sucking product and preparation method thereof | |
| CN101011184A (en) | Tobacco substitution chrysanthemum health cigarette | |
| CN105167177B (en) | Cigarette flavones essence cigarette pearl, preparation method and application | |
| CN104547682B (en) | A kind of composition of effect of relievining asthma that wet one's whistle with removing heat from the lung and relieving sorethroat | |
| CN104905406B (en) | The cigarette of the essence containing flavone compound mouth stick preparation method and application | |
| CN105011369B (en) | The cigarette of the essence containing flavones mouth stick preparation method and application | |
| CN101862028B (en) | Wintergreen extraction method, preparation method of cigarette comprising wintergreen extract | |
| CN109043641A (en) | The cigarette and its manufacture craft of eaglewood leaf and linaloe oil mixing | |
| CN111642786B (en) | Chinese herbal medicine tea cigarette with epidemic prevention and health care effects and application thereof | |
| CN107129869A (en) | Smooth breathing essential oil and preparation method and application | |
| CN103005677B (en) | Sage scent type snuff and preparation method thereof | |
| CN103040098B (en) | Lavender odor type snuff | |
| CN103156271B (en) | Shisha paste containing extractive from natural plant Tacca chantrieri Andre and preparation method thereof | |
| CN109998151A (en) | Medium chain triglyceride is improving and/or is reducing the application in respiratory tract | |
| CN107568785A (en) | A kind of health care cigarette that can be used for smoking cessation and preparation method thereof | |
| CN101125026A (en) | Green cigarette | |
| CN103054163B (en) | Lily-flavored snuff | |
| CN103027371B (en) | Myristica fragrans type snuff | |
| CN101103843A (en) | Cigarette without nicotin | |
| CN105749205A (en) | Traditional Chinese medicine fritillaria cirrhosa and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |